Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2025 for Revance Therapeutics, Inc., €59k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Olivia C. Ware: trading record in brief
Filings by Olivia C. Ware span 2 companies, the busiest being Revance Therapeutics, Inc. and Arcellx, Inc. In total, 7 filings cover trades dated from 5 May 2021 to 4 February 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 6 February 2025 came the latest disclosure, a transaction for €59k in Revance Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Olivia C. Ware
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
16,675 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015354:0
15,000 shares0Common StockSEC:0001479290-24-000090:0
9,402 shares@ US$7.6151.7% of flowCommon StockSEC:0001415889-24-011120:0
9,000 shares@ US$7.6148.3% of flowCommon StockSEC:0001415889-24-008340:0
3,534 shares0Common StockSEC:0001479290-23-000063:0
6,059 shares0Common StockSEC:0001479290-22-000058:0
674 shares0Common StockSEC:0001479290-21-000118:0
7 of 7 declarations
